VIS-TAP-TAPPNCT07264699
Visually Guided TAP Block in Laparoscopic TAPP Hernia Repair
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 3 versions: 3 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 8 more changesShow less
- Eligibility criteria expanded, about 13 words
- Trial completed
- Final enrollment: 116 participants (planned 100)
- Primary completion date changed from estimate of Dec 2026 to Oct 31, 2026
- Interventions modified
- Secondary endpoints: 5 to 10
- Study description shortened, about 33 words
- Site details revised
- Notable Trial status: Not Yet Recruiting to Recruiting
- Start date changed from estimate of Nov 25, 2025 to Dec 4, 2025
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Secondary (10)
Show 5 moreShow less
Arms and interventions
After pneumoperitoneum is established and the laparoscope is introduced, a bilateral Transversus Abdominis Plane (TAP) block is performed under direct laparoscopic vision. Using a needle and syringe, 20 ml of 0.25% bupivacaine is injected on each side, approximately 2 cm below the costal margin in the anterior axillary line. The correct placement of the local anesthetic is confirmed by the visible "Doyle's bulge sign." Patients receive standard general anesthesia and postoperative pain management identical to the control group.
Participants undergo standard laparoscopic inguinal hernia repair using the transabdominal preperitoneal (TAPP) technique. Instead of bupivacaine, 20 mL of 0.9% sodium chloride is injected on each side (40 mL total) as a placebo, using the same visually guided injection technique and anatomical sites as in the experimental group. All patients receive the same standardized general anesthesia protocol and postoperative analgesic regimen as those in the experimental group.
Procedures: Laparoscopic Transversus Abdominis Plane (TAP) Block with Bupivacaine
Drugs: 0.9% sodium chloride (placebo)
Sites
1 site in 1 country
- University Clinical Hospital in Olsztyn, Department of General and Oncological SurgeryOlsztyn, Warmisko-mazurskie, Poland